Home > Qtrly Results > ORCHID PHARMA

ORCHID PHARMA
Quarterly Results Analysis [Mar2026]

ORCHID PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Quarterly Results

Consolidated Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Revenues ₹238 Cr ₹207 Cr ₹194 Cr ₹173 Cr ₹237 Cr ₹217 Cr ₹223 Cr ₹244 Cr
Expenses ₹211 Cr ₹206 Cr ₹195 Cr ₹159 Cr ₹209 Cr ₹191 Cr ₹192 Cr ₹212 Cr
Operating Income ₹27 Cr ₹2 Cr ₹-1 Cr ₹14 Cr ₹28 Cr ₹26 Cr ₹30 Cr ₹32 Cr
Other Income ₹7 Cr ₹6 Cr ₹11 Cr ₹11 Cr ₹4 Cr ₹8 Cr ₹8 Cr ₹8 Cr
Interest ₹3 Cr ₹3 Cr ₹4 Cr ₹3 Cr ₹4 Cr ₹4 Cr ₹3 Cr ₹3 Cr
Depreciation ₹9 Cr ₹9 Cr ₹9 Cr ₹9 Cr ₹9 Cr ₹9 Cr ₹9 Cr ₹8 Cr
Profit Before Tax ₹23 Cr ₹-12 Cr ₹-3 Cr ₹14 Cr ₹19 Cr ₹22 Cr ₹26 Cr ₹28 Cr
Profit After Tax ₹23 Cr ₹-12 Cr ₹-3 Cr ₹14 Cr ₹19 Cr ₹22 Cr ₹26 Cr ₹28 Cr
EPS ₹4.69 ₹-2.49 ₹-1.13 ₹2.94 ₹4.40 ₹4.10 ₹5.37 ₹5.79
Industry Peers & Returns1W1M1Y
ORCHID PHARMA 1.9% 18.2% 18.8%
SUN PHARMACEUTICAL INDUSTRIES 0.4% -4.6% 6.9%
DIVIS LABORATORIES 0.7% -1.1% 2.1%
TORRENT PHARMACEUTICALS 2.9% -1.2% 42.7%
CIPLA -1.5% 5.5% -6.5%
DR REDDYS LABORATORIES 0.4% -0.6% 1.3%
MANKIND PHARMA 0.7% -4% 1.9%
LUPIN NA 0.1% 16.5%
ZYDUS LIFESCIENCES 1.2% 14.8% 18.7%

ORCHID PHARMA Quarterly Revenues

Revenues
Q-o-Q

14.64 %

Y-o-Y

0.05 %

Quarters Revenues % Change
Mar2026 ₹238 Cr
14.64
Dec2025 ₹207 Cr
7.10
Sep2025 ₹194 Cr
11.91
Jun2025 ₹173 Cr
-27.18
Mar2025 ₹237 Cr
9.26
Dec2024 ₹217 Cr
-2.41
Sep2024 ₹223 Cr
-8.88
Jun2024 ₹244 Cr -

ORCHID PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

1,618.75 %

Y-o-Y

-4.01 %

Quarters Operating Profit % Change
Mar2026 ₹27 Cr
1,618.75
Dec2025 ₹2 Cr
Positive
Sep2025 ₹-1 Cr
Negative
Jun2025 ₹14 Cr
-49.35
Mar2025 ₹28 Cr
6.15
Dec2024 ₹26 Cr
-13.10
Sep2024 ₹30 Cr
-6.63
Jun2024 ₹32 Cr -
Operating Margins
Q-o-Q

1,408.00 %

Y-o-Y

-3.99 %

Quarters Operating Margin% % Change
Mar2026 11.31%
1,408.00
Dec2025 0.75%
Positive
Sep2025 -0.76%
Negative
Jun2025 8.2%
-30.39
Mar2025 11.78%
-2.89
Dec2024 12.13%
-10.94
Sep2024 13.62%
2.48
Jun2024 13.29% -

ORCHID PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

Positive

Y-o-Y

19.08 %

Quarters Profit After Tax % Change
Mar2026 ₹23 Cr
Positive
Dec2025 ₹-12 Cr
Negative
Sep2025 ₹-3 Cr
Negative
Jun2025 ₹14 Cr
-28.35
Mar2025 ₹19 Cr
-14.77
Dec2024 ₹22 Cr
-13.32
Sep2024 ₹26 Cr
-8.40
Jun2024 ₹28 Cr -
PAT Margins
Q-o-Q

Positive

Y-o-Y

18.98 %

Quarters PAT Margin(%) % Change
Mar2026 9.59 %
Positive
Dec2025 -5.86 %
Negative
Sep2025 -1.72 %
Negative
Jun2025 7.93 %
-1.61
Mar2025 8.06 %
-21.97
Dec2024 10.33 %
-11.18
Sep2024 11.63 %
0.52
Jun2024 11.57 % -

ORCHID PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

Positive

Y-o-Y

6.59 %

Quarters EPS % Change
Mar2026 ₹4.69
Positive
Dec2025 ₹-2.49
Negative
Sep2025 ₹-1.13
Negative
Jun2025 ₹2.94
-33.18
Mar2025 ₹4.4
7.32
Dec2024 ₹4.1
-23.65
Sep2024 ₹5.37
-7.25
Jun2024 ₹5.79 -

You may also like the below Video Courses